A panel of expert oncologists review clinical cases and provide a comprehensive discussion on the recent clinical advances in PSMA PET imaging for prostate cancer.
EP. 1: The Evolution of Imaging Techniques in Prostate Cancer
A panel of expert oncologists in prostate cancer give an overview of the evolution of imaging techniques used for patients with prostate cancer.
EP. 2: The Utility of PSMA PET in Prostate Cancer
Expert oncologists give an overview of prostate-specific membrane antigen (PSMA) and discuss its utility for the treatment of prostate cancer.
EP. 3: Clinical Development of PSMA-Targeted Therapies
A comprehensive discussion surrounding the clinical development of PSMA-targeted therapies for patients with prostate cancer.
EP. 4: Clinical Practices of PSMA-Targeted Agents in Prostate Cancer
Clinical oncologists share their best practices for the utilization of PSMA-targeted agents in patients with prostate cancer.
EP. 5: Multidisciplinary Approaches in PSMA PET for Prostate Cancer
Dr Helfand and panelists outline the incorporation of multidisciplinary approaches to the management of prostate cancer.
EP. 6: Patient Profile 1: A 51-Year-Old Man with High-Risk Localized Prostate Cancer
A panel of experts in prostate cancer present the case of a 51-year-old man with high-risk localized prostate cancer.
EP. 7: PSMA PET Imaging and Clinical Perspectives from Patient Profile 1
Oncologists share their clinical perspectives of PSMA PET imaging and the results of the patient case.
EP. 8: LIGHTHOUSE Trial and The Role of 18F-rhPSMA-7.3 for Staging of Prostate Cancer
Dr. Chapin and fellow expert oncologists discuss the latest data from the LIGHTHOUSE trial, evaluating 18F-rhPSMA-7.3 for staging patients with prostate cancer.
2 Commerce Drive Cranbury, NJ 08512